YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Strattera
ADHD drugmakers must tell of risks
Feb 23, 2007 | SOUTH FLORIDA SUN-SENTINEL
Federal officials told the makers of Ritalin, Adderall, Strattera and all other drugs for treatment of attention deficit hyperactivity disorder, or...
Government wants further ADHD drug warnings
Feb 22, 2007 | Baltimore Sun
The makers of Ritalin, Adderall, Strattera and other drugs treating attention-deficit hyperactivity disorder were advised by the government Wednesday...
ADHD drug makers to warn of side effects
Feb 21, 2007 | AP
Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart...
Drug makers to add warnings to ADHD pills
Feb 21, 2007 | AP
Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart...
ADHD Drugs to Get New Warnings
Feb 21, 2007 | NewsInferno.com
The U.S. Food and Drug Administration (FDA) announced today that it is ordering all manufacturers of attention deficit hyperactivity disorder (ADHD)...
FDA orders warning 'guides' for ADHD drugs
Feb 21, 2007 | USA Today
Pharmacists will soon begin handing out consumer-friendly "medication guides" about cardiovascular and psychiatric problems linked to...
FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Event
Feb 21, 2007 | www.fda.gov
The U.S. Food and Drug Administration (FDA) today directed the manufacturers of all drug products approved for the treatment of Attention Deficit...
ADD Drug Strattera, Already Under FDA Scrutiny, Raising New Safety Concerns in UK as Well
Feb 21, 2006 | Newsinferno News Staff
Although pharmaceutical giant Eli Lilly (Lilly) continues to maintain that its attention deficit drug, Strattera, is safe, the company’s...
British raise issues with ADHD drug
Feb 21, 2006 | www.IndyStar.com
British authorities are raising safety concerns about Strattera, the attention deficit hyperactivity disorder drug made by Indianapolis...
FDA to probe ADHD drug safety
Jan 5, 2006 | Pharma Times
The US Food and Drug Administration is planning to review the cardiovascular risks of attention-deficit hyperactivity disorder treatments, and has...
Strattera
